Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance

Oncogene

Volumn 20, Issue 11, 2001, Pages 1300-1306

  Turton, Nicola J ^a   Judah, David J ^a   Riley, Joan ^a   Davies, Reginald ^a   Lipson, Doron ^b   Styles, Jerry A ^a   Smith, Andrew G ^a   Gant, Timothy W ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Breast cancer; cDNA microarrays; Differential gene expression; Doxorubicin resistance; Genomic amplification; Multidrug resistance

Indexed keywords

DOXORUBICIN; ESTROGEN RECEPTOR; GENE PRODUCT; GLYCOPROTEIN P; INTERSTITIAL COLLAGENASE; KERATIN; MULTIDRUG RESISTANCE PROTEIN 1; OXYTOCIN RECEPTOR; PROTEIN ABCB4; PROTEIN BAK; PROTEIN PGY3; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM CELL; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENOME; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; DOXORUBICIN; DRUG RESISTANCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION PROFILING; HUMANS; PHENOTYPE; RECEPTORS, ESTROGEN;

EID: 0035868371     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204235     Document Type: Article

References (31)